E3 ubiquitin-protein ligase CBL
| GO Term | Evidence Code | Reference |
|---|---|---|
| ubiquitin-dependent protein catabolic process | ||
| ubiquitin-dependent protein catabolic process | ||
| protein monoubiquitination | ||
| DNA damage response | ||
| cellular response to DNA damage stimulus |
| GO Term | Evidence Code | Reference |
|---|---|---|
| phosphotyrosine residue binding | ||
| ubiquitin-protein transferase activity | ||
| ubiquitin-protein transferase activity | ||
| calcium ion binding | ||
| zinc ion binding |
|
|
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 245 |
|
|||
| 511 |
|
|||
| 512 |
|
|||
| 514 |
|
|||
| 589 |
|
|||
| 601 |
|
|||
| 604 |
|
|||
| 605 |
|
|||
| 606 |
|
|||
| 610 |
|
| Pathway Name | Organism |
|---|---|
| Cargo recognition for clathrin-mediated endocytosis | Homo sapiens |
| Clathrin-mediated endocytosis | Homo sapiens |
| Constitutive Signaling by EGFRvIII | Homo sapiens |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | Homo sapiens |
| EGFR downregulation | Homo sapiens |
| FLT3 signaling by CBL mutants | Homo sapiens |
| InlB-mediated entry of Listeria monocytogenes into host cell | Homo sapiens |
| Interleukin-6 signaling | Homo sapiens |
| Negative regulation of FGFR1 signaling | Homo sapiens |
| Negative regulation of FGFR2 signaling | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050458 | juvenile myelomonocytic leukemia | |
| DOID:0070004 | myeloid neoplasm | |
| DOID:3908 | lung non-small cell carcinoma | |
| DOID:6000 | congestive heart failure | |
| DOID:9119 | acute myeloid leukemia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026